OBJECTIVE: The goal of this study is to examine the relationship between socioeconomic status (SES) and both positive and negative mental health (MH) outcomes in a population-based sample of colorectal cancer survivors. On the basis of theoretical conceptualizations of trauma and posttraumatic growth, low SES was hypothesized to be positively associated with both greater negative MH outcomes (e.g., distress) and greater positive MH outcomes (e.g., growth). METHODS: Colorectal cancer survivors (n = 1300; 57% male; mean age 69.4 and 4.0 years post-diagnosis) were recruited using a regional, population-based cancer registry in the Netherlands and completed a questionnaire assessing current negative and positive MH outcomes. Low, medium, and high SES respondents were identified using an area-level indicator of SES based on aggregated individual fiscal data on monetary home value and household income. RESULTS: Analysis of covariance and logistic regression analyses indicated that low SES was a risk factor for greater negative MH outcomes. Relative to high SES survivors, low SES survivors reported poorer status on nine indices of MH, and high SES survivors were about 50% less likely to report clinically important levels of anxiety and depression. Results provided partial support for the hypothesis low SES was a 'risk' factor for greater positive MH outcomes. Relative to high SES survivors, low SES survivors reported greater positive MH outcomes on 2 of 5 positive MH indices examined (Positive Self-Evaluation, Meaning of Cancer). CONCLUSIONS: Study findings are the first to suggest that low SES might increase the likelihood of both greater negative as well as positive MH outcomes in cancer survivors.
OBJECTIVE: The goal of this study is to examine the relationship between socioeconomic status (SES) and both positive and negative mental health (MH) outcomes in a population-based sample of colorectal cancer survivors. On the basis of theoretical conceptualizations of trauma and posttraumatic growth, low SES was hypothesized to be positively associated with both greater negative MH outcomes (e.g., distress) and greater positive MH outcomes (e.g., growth). METHODS:Colorectal cancer survivors (n = 1300; 57% male; mean age 69.4 and 4.0 years post-diagnosis) were recruited using a regional, population-based cancer registry in the Netherlands and completed a questionnaire assessing current negative and positive MH outcomes. Low, medium, and high SES respondents were identified using an area-level indicator of SES based on aggregated individual fiscal data on monetary home value and household income. RESULTS: Analysis of covariance and logistic regression analyses indicated that low SES was a risk factor for greater negative MH outcomes. Relative to high SES survivors, low SES survivors reported poorer status on nine indices of MH, and high SES survivors were about 50% less likely to report clinically important levels of anxiety and depression. Results provided partial support for the hypothesis low SES was a 'risk' factor for greater positive MH outcomes. Relative to high SES survivors, low SES survivors reported greater positive MH outcomes on 2 of 5 positive MH indices examined (Positive Self-Evaluation, Meaning of Cancer). CONCLUSIONS: Study findings are the first to suggest that low SES might increase the likelihood of both greater negative as well as positive MH outcomes in cancer survivors.
Authors: Martijn J L Bours; Bernadette W A van der Linden; Renate M Winkels; Fränzel J van Duijnhoven; Floortje Mols; Eline H van Roekel; Ellen Kampman; Sandra Beijer; Matty P Weijenberg Journal: Oncologist Date: 2016-02-24
Authors: Jean A McDougall; Cindy K Blair; Charles L Wiggins; Michael B Goodwin; Vi K Chiu; Ashwani Rajput; Anita Y Kinney Journal: J Cancer Surviv Date: 2019-05-20 Impact factor: 4.442
Authors: Abigail S Robbertz; David M Weiss; Farrukh T Awan; John C Byrd; Kerry A Rogers; Jennifer A Woyach Journal: Support Care Cancer Date: 2019-07-22 Impact factor: 3.603
Authors: Jamaica R M Robinson; Amanda I Phipps; Wendy E Barrington; Philip M Hurvitz; Lianne Sheppard; Rachel C Malen; Polly A Newcomb Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-05-04 Impact factor: 4.254
Authors: Christine J Kurian; Amy E Leader; Melissa S Y Thong; Scott W Keith; Charnita M Zeigler-Johnson Journal: BMC Public Health Date: 2018-08-23 Impact factor: 3.295
Authors: Yvonne M J Goërtz; Milou Looijmans; Judith B Prins; Daisy J A Janssen; Melissa S Y Thong; Jeannette B Peters; Chris Burtin; Yvonne Meertens-Kerris; Arnold Coors; Jean W M Muris; Mirjam A G Sprangers; Emiel F M Wouters; Jan H Vercoulen; Martijn A Spruit Journal: BMJ Open Date: 2018-04-10 Impact factor: 2.692
Authors: Victoria M White; Karolina Lisy; Andrew Ward; Eli Ristevski; Melanie Clode; Kate Webber; Jon Emery; Maarten J Ijzerman; Nina Afshar; Jeremy Millar; Peter Gibbs; Sue Evans; Michael Jefford Journal: Support Care Cancer Date: 2022-03-12 Impact factor: 3.359